Revathy Nadhan to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Revathy Nadhan has written about Drug Resistance, Neoplasm.
Connection Strength
0.395
-
Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
Score: 0.208
-
ß-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue. Carcinogenesis. 2019 Nov 25; 40(11):1415-1426.
Score: 0.153
-
Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer. Crit Rev Oncol Hematol. 2018 Mar; 123:74-82.
Score: 0.034